Lantern Pharma, Inc. (LTRN)
3.80
+0.05
(+1.33%)
USD |
NASDAQ |
Jun 09, 15:54
Lantern Pharma EPS Diluted (TTM) : -1.445 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Replimune Group, Inc. | -3.582 |
| Arrowhead Pharmaceuticals, Inc. | -2.148 |
| Oncolytics Biotech, Inc. | -0.2517 |
| Sangamo Therapeutics, Inc. | -0.383 |
| Sarepta Therapeutics, Inc. | -0.9641 |